Financial Strategies Group, Inc. Pfizer Inc Transaction History

Financial Strategies Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$43.76 - $53.42 $7,526 - $9,188	172 Added 1.55%	11,287 $493,000
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $1,302 - $1,544	28 Added 0.25%	11,115 $583,000
Q1 2022 Apr 29, 2022	BUY	$45.75 - $56.69 $274 - $340	6 Added 0.05%	11,087 $574,000
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $8,387 - $12,433	-203 Reduced 1.8%	11,081 $654,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $7,025 - $9,025	179 Added 1.61%	11,284 $485,000
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $21,007 - $23,797	585 Added 5.56%	11,105 $435,000
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $837 - $944	-25 Reduced 0.24%	10,520 $381,000
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $4,618 - $5,873	138 Added 1.33%	10,545 $388,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $342,598 - $388,805	10,407 New	10,407 $408,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Financial Strategies Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Strategies Group, Inc. with notifications on news.